To date, our attorneys have recovered more than one billion dollars in settlements and verdicts for clients across New York
But we are deeply troubled by the direct-to-consumer peptide industry
What we can say is that GLP-1 agonists offer a systemic approach to weight loss by reducing appetite and improving metabolic health, which can lead to gradual, widespread fat reduction
We expect that the majority of lawsuits will still allege injury to the stomach and bowel
DEREK MUNRO: Yeah, thats like one of the, I think most important components of the usage of them is especially with women who might be otherwise not even integrating it into their regular life, they just end up eating less of what is already a nutrient poor or protein poor diet and arent strength training as much as I guess proportionally to men
Both groups attended monthly one-hour lifestyle-advice seminars covering diet and exercise